Moxibustion Inhibits the Expression of Colonic NLRP3 through miR7/RNF183/NF-κB Signaling Pathway in UC Rats

Background Moxibustion has been recognized as an effective approach for ulcerative colitis, yet its mechanism is not clear. The research aimed to investigate the influence of moxibustion on the activation of NLRP3 inflammasome and its mechanism in treating ulcerative colitis by observing miR7/RNF183 inducing IκB α ubiquitination to regulate NF-κB signaling pathway in an ulcerative colitis rat model. Methods An ulcerative colitis rat model was established by unlimited access to self-administration of 3.5% (w/v) dextran sulfate sodium solution. Mild moxibustion was applied to bilateral Tianshu points (ST25) in the moxa-stick moxibustion group; rats in the control group were intervened by intraperitoneal injection of ubiquitination inhibitor, MG132. The disease activity index was determined at the end of the intervention; colon injury was observed and scored after hematoxylin-eosin staining; the immunohistochemical method was adopted to detect the expressions of colonic IL-1β and NLRP3 proteins; Western blot determined the expressions of RNF183, IκB α, and NF-κB p65 proteins in the colon; the immunofluorescence test was used to observe the coexpression of IκB α/ubiquitin and IκB α/RNF183 proteins in the colon; immunoprecipitation assay was adopted to observe the interaction between IκB α and RNF183 proteins; and quantitative real-time polymerase chain reaction determined the expression of colonic miR7. Results Moxibustion lowered the disease activity index, manifesting as restored colonic tissue and reduced inflammatory reaction, and decreased expression levels of NLRP3 and IL-1β proteins, compared with the model group. It also reduced colonic expression of NF-κB p65 protein, together with the increased level of IκB α protein and weaker expression levels of ubiquitin and RNF183 proteins and mRNAs and stronger expression of miR7. There were no significant differences between the moxa-stick moxibustion group and the control group except the expressions of RNF183 protein and mRNA and miR7. Conclusion Moxibustion encourages the recovery of colon injury probably by regulating the expression of NLRP3 protein in ulcerative colitis rats through miR7/RNF183/NF-κB signaling pathway.

[1]  J. Yamamoto-Furusho,et al.  Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease. , 2020, Gastroenterologia y hepatologia.

[2]  B. Carter,et al.  Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition , 2020, Quality of Life Research.

[3]  Li Li,et al.  Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease , 2020, Mediators of inflammation.

[4]  M. Costache,et al.  Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis , 2020, Cells.

[5]  Zhe Ma,et al.  Typical ulcerative colitis treated by herbs-partitioned moxibustion: A case report , 2020, World journal of clinical cases.

[6]  Xiao-Peng Ma,et al.  Regulatory effects of moxibustion on ubiquitin and NLRP3 proteins in colon of ulcerative colitis rats , 2020, Journal of Acupuncture and Tuina Science.

[7]  Yu Cheng,et al.  Electroacupuncture Relieves Pain and Attenuates Inflammation Progression Through Inducing IL-10 Production in CFA-Induced Mice , 2020, Inflammation.

[8]  Xiang Gao,et al.  Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. , 2020, International dental journal.

[9]  Shuguang Yu,et al.  Electroacupuncture and Moxibustion Regulate Hippocampus Glia and Mitochondria Activation in DSS-Induced Colitis Mice , 2020, Evidence-based complementary and alternative medicine : eCAM.

[10]  D. Liang,et al.  miRNA-129/FBW7/NF-κB, a Novel Regulatory Pathway in Inflammatory Bowel Disease , 2019, Molecular therapy. Nucleic acids.

[11]  Ling-fen Xu,et al.  Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model , 2019, Inflammation.

[12]  Jana G Hashash,et al.  A comprehensive review and update on ulcerative colitis. , 2019, Disease-a-month : DM.

[13]  Guanghua Huang,et al.  Etiology and pathogenesis of ulcerative colitis from the perspective of modern medicine , 2019, World Chinese Journal of Digestology.

[14]  Wei Qi,et al.  MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy , 2019, Scientific Reports.

[15]  Houhui Song,et al.  Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors , 2019, Cell Death & Disease.

[16]  Weifeng Yu,et al.  Electroacupuncture Pretreatment Attenuates Inflammatory Lung Injury After Cardiopulmonary Bypass by Suppressing NLRP3 Inflammasome Activation in Rats , 2019, Inflammation.

[17]  Ying Li,et al.  Electroacupuncture at ST-36 ameliorates DSS-induced acute colitis via regulating macrophage polarization induced by suppressing NLRP3/IL-1β and promoting Nrf2/HO-1. , 2019, Molecular immunology.

[18]  G. Courtois,et al.  The Many Roles of Ubiquitin in NF-κB Signaling , 2018, Biomedicines.

[19]  Junjie Hu,et al.  Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL , 2018, Proceedings of the National Academy of Sciences.

[20]  D. Stein.  Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease. , 2017, Gastroenterology clinics of North America.

[21]  Yin Shi,et al.  Effect of Electro-Acupuncture and Moxibustion on Brain Connectivity in Patients with Crohn’s Disease: A Resting-State fMRI Study , 2017, Front. Hum. Neurosci..

[22]  Stefan Wirtz,et al.  Chemically induced mouse models of acute and chronic intestinal inflammation , 2017, Nature Protocols.

[23]  Hyo Sun Jin,et al.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling , 2017, Immunology and cell biology.

[24]  W. Qin,et al.  Different brain responses to electro-acupuncture and moxibustion treatment in patients with Crohn’s disease , 2016, Scientific Reports.

[25]  Y. Huang,et al.  Review of Clinical Studies of the Treatment of Ulcerative Colitis Using Acupuncture and Moxibustion , 2016, Gastroenterology research and practice.

[26]  Qingnian Xu,et al.  Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2016, Evidence-based complementary and alternative medicine : eCAM.

[27]  Tie-ming Ma,et al.  Moxibustion regulates inflammatory mediators and colonic mucosal barrier in ulcerative colitis rats. , 2016, World journal of gastroenterology.

[28]  Minhu Chen,et al.  E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[29]  Luyi Wu,et al.  Herb-Partitioned Moxibustion Regulates the TLR2/NF-κB Signaling Pathway in a Rat Model of Ulcerative Colitis , 2015, Evidence-based complementary and alternative medicine : eCAM.

[30]  Chunhui Bao,et al.  Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients. , 2015, World journal of gastroenterology.

[31]  Xiaoming Fan,et al.  Ghrelin ameliorates intestinal barrier dysfunction in experimental colitis by inhibiting the activation of nuclear factor-kappa B. , 2015, Biochemical and biophysical research communications.

[32]  Tie-ming Ma,et al.  Role of moxibustion in inflammatory responses during treatment of rat ulcerative colitis. , 2014, World journal of gastroenterology.

[33]  Qiang Xu,et al.  A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. , 2013, Biochemical pharmacology.

[34]  G. Rogler,et al.  Downregulation of the Ubiquitin-Proteasome System in Normal Colonic Macrophages and Reinduction in Inflammatory Bowel Disease , 2012, Digestion.

[35]  Jianni Qi,et al.  TLR‐induced NF‐κB activation regulates NLRP3 expression in murine macrophages , 2012, FEBS letters.

[36]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[37]  Wei Zhang,et al.  Down-regulation of Protein and mRNA Expression of IL-8 and ICAM-1 in Colon Tissue of Ulcerative Colitis Patients by Partition-Herb Moxibustion , 2009, Digestive Diseases and Sciences.

[38]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[39]  W. Falk,et al.  Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis , 2003, Clinical and experimental immunology.

[40]  M. Magnani,et al.  The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). , 2000, Current drug targets.

[41]  Michael A. Fiedler,et al.  Inhibition of TNF- α -induced NF- κ B Activation and IL-8 Release in A549 Cells with the Proteasome Inhibitor MG-132 , 1998 .

[42]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[43]  L. Brandt,et al.  Clinical characteristics and natural history of colitis in the elderly. , 1982, The American journal of gastroenterology.